1. Home
  2. ACHV vs MBOT Comparison

ACHV vs MBOT Comparison

Compare ACHV & MBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACHV
  • MBOT
  • Stock Information
  • Founded
  • ACHV N/A
  • MBOT 2010
  • Country
  • ACHV United States
  • MBOT United States
  • Employees
  • ACHV N/A
  • MBOT N/A
  • Industry
  • ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • MBOT Medical/Dental Instruments
  • Sector
  • ACHV Health Care
  • MBOT Health Care
  • Exchange
  • ACHV Nasdaq
  • MBOT Nasdaq
  • Market Cap
  • ACHV 167.6M
  • MBOT 184.8M
  • IPO Year
  • ACHV N/A
  • MBOT N/A
  • Fundamental
  • Price
  • ACHV $4.93
  • MBOT $2.12
  • Analyst Decision
  • ACHV Strong Buy
  • MBOT Strong Buy
  • Analyst Count
  • ACHV 1
  • MBOT 1
  • Target Price
  • ACHV $12.00
  • MBOT $12.00
  • AVG Volume (30 Days)
  • ACHV 2.4M
  • MBOT 2.6M
  • Earning Date
  • ACHV 11-06-2025
  • MBOT 11-13-2025
  • Dividend Yield
  • ACHV N/A
  • MBOT N/A
  • EPS Growth
  • ACHV N/A
  • MBOT N/A
  • EPS
  • ACHV N/A
  • MBOT N/A
  • Revenue
  • ACHV N/A
  • MBOT N/A
  • Revenue This Year
  • ACHV N/A
  • MBOT N/A
  • Revenue Next Year
  • ACHV N/A
  • MBOT $1,107.73
  • P/E Ratio
  • ACHV N/A
  • MBOT N/A
  • Revenue Growth
  • ACHV N/A
  • MBOT N/A
  • 52 Week Low
  • ACHV $1.84
  • MBOT $0.89
  • 52 Week High
  • ACHV $5.78
  • MBOT $4.67
  • Technical
  • Relative Strength Index (RSI)
  • ACHV 63.71
  • MBOT 30.39
  • Support Level
  • ACHV $4.77
  • MBOT $1.99
  • Resistance Level
  • ACHV $5.42
  • MBOT $2.31
  • Average True Range (ATR)
  • ACHV 0.44
  • MBOT 0.16
  • MACD
  • ACHV -0.00
  • MBOT -0.03
  • Stochastic Oscillator
  • ACHV 58.94
  • MBOT 14.92

About ACHV Achieve Life Sciences Inc.

Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.

About MBOT Microbot Medical Inc.

Microbot Medical Inc is a clinical-stage medical device company specializing in the research, design and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. It is focused on leveraging its robotic technologies to redefine surgical robotics while improving surgical outcomes for patients. Using its LIBERTY technological platform, the company is developing the first-ever fully disposable robot for various endovascular interventional procedures.

Share on Social Networks: